VetSheet

Polysulfated Glycosaminoglycan

Polysulfated glycosaminoglycan (PSGAG)

Ophthalmic Agent / Chondroprotectivetopical ophthalmicDogsHorses

Also known as: Adequan Β· PSGAG

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

1 drop of a 5% PSGAG solution in artificial tearstopical ophthalmicΒ· TID

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

🌎 NA β€” North America🌍 EU β€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Indolent corneal ulcers1 drop of a 5% PSGAG solution in artificial tearstopical ophthalmicTIDβ€”πŸŒŽ NA
  • Indolent corneal ulcers: Anecdotal efficacy

Horses

IndicationDoseRouteFrequencyDurationRegion
Indolent corneal ulcers1 drop of a 5% PSGAG solution in artificial tearstopical ophthalmicTIDup to 3 weeks🌎 NA
  • Indolent corneal ulcers: 86% of eyes treated were considered healed within 3 weeks

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Polysulfated glycosaminoglycan (PSGAG) was originally developed for use in degenerative osteoarthritis but has intriguing properties for corneal ulcer management.

  • Anecdotally effective in promoting healing of indolent corneal ulcers in dogs.
  • Shown to be highly effective (86% healed within 3 weeks) for indolent ulcers in horses.

​Clinical Pearl:​ While surgical keratectomy remains the most reliable treatment for indolent ulcers, topical PSGAG offers a non-invasive adjunctive or alternative medical therapy.

Mechanism of action

Inhibits multiple degradative enzymes (lysozyme, hyaluronidase, and serine proteases) β†’ decreases prostaglandin E2 synthesis β†’ reduces production of toxic superoxide radicals β†’ increases synthesis of collagen proteoglycans and hyaluronic acid.

Safety & warnings

Precautions

Surgical keratectomy remains the most reliable treatment for indolent ulcers. Efficacy in dogs is currently anecdotal.

Monitoring

  • Corneal ulcer healing via fluorescein staining

Available products

Formulations

  • Ophthalmic solution 5% (compounded from injectable)

Veterinary

  • Adequan injection (diluted 1:1 with sterile artificial tears to produce a 5% PSGAG solution)

Regulatory status

No regulatory data for: πŸ‡ΊπŸ‡Έ US Β· πŸ‡ͺπŸ‡Ί EU Β· πŸ‡¬πŸ‡§ UK Β· πŸ‡­πŸ‡° HK Β· πŸ‡ΉπŸ‡Ό TW Β· πŸ‡―πŸ‡΅ JP Β· πŸ‡°πŸ‡· KR Β· πŸ‡¦πŸ‡Ί AU

Storage & stability

Store compounded ophthalmic solutions as directed by the compounding pharmacist, typically refrigerated.

Client information

Apply the eye drops exactly as directed by your veterinarian. Monitor your pet's eye for any signs of increased redness, squinting, or discharge, and contact your clinic if the eye seems more painful.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.